Shanghai Shen Lian Biomedical Corporation (688098.SS)
CNY 5.89
(0.68%)
CNY 5.89
(0.68%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 86.92 Million CNY | -19.67% |
| 2022 | 108.2 Million CNY | -13.76% |
| 2021 | 125.47 Million CNY | 6.15% |
| 2020 | 118.2 Million CNY | -28.93% |
| 2019 | 166.33 Million CNY | -8.2% |
| 2018 | 181.18 Million CNY | 26.77% |
| 2017 | 142.91 Million CNY | 0.42% |
| 2016 | 142.32 Million CNY | -17.69% |
| 2015 | 172.9 Million CNY | -39.82% |
| 2014 | 287.32 Million CNY | 40.88% |
| 2013 | 203.94 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 106.33 Million CNY | 5.37% |
| 2024 Q2 | 100.91 Million CNY | 11.87% |
| 2024 Q1 | 90.2 Million CNY | 3.77% |
| 2023 Q4 | 86.92 Million CNY | -2.93% |
| 2023 FY | 86.92 Million CNY | -19.67% |
| 2023 Q3 | 89.55 Million CNY | 14.91% |
| 2023 Q1 | 87.06 Million CNY | -19.54% |
| 2023 Q2 | 77.93 Million CNY | -10.49% |
| 2022 Q2 | 114.6 Million CNY | -0.35% |
| 2022 FY | 108.2 Million CNY | -13.76% |
| 2022 Q1 | 115 Million CNY | -8.35% |
| 2022 Q4 | 108.2 Million CNY | -14.71% |
| 2022 Q3 | 126.87 Million CNY | 10.71% |
| 2021 Q2 | 119.24 Million CNY | 16.41% |
| 2021 Q3 | 146.12 Million CNY | 22.55% |
| 2021 Q4 | 125.47 Million CNY | -14.13% |
| 2021 Q1 | 102.42 Million CNY | -13.35% |
| 2021 FY | 125.47 Million CNY | 6.15% |
| 2020 FY | 118.2 Million CNY | -28.93% |
| 2020 Q4 | 118.2 Million CNY | -25.29% |
| 2020 Q3 | 158.22 Million CNY | 4.84% |
| 2020 Q2 | 150.91 Million CNY | -2.77% |
| 2020 Q1 | 155.21 Million CNY | -6.68% |
| 2019 Q4 | 166.33 Million CNY | -0.64% |
| 2019 FY | 166.33 Million CNY | -8.2% |
| 2019 Q2 | 148.28 Million CNY | 0.0% |
| 2019 Q3 | 167.4 Million CNY | 12.89% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 FY | 181.18 Million CNY | 26.77% |
| 2018 Q4 | 181.18 Million CNY | 0.0% |
| 2017 Q1 | 131.55 Million CNY | -7.57% |
| 2017 Q4 | 142.91 Million CNY | 0.0% |
| 2017 FY | 142.91 Million CNY | 0.42% |
| 2017 Q2 | 131.55 Million CNY | 0.0% |
| 2016 Q1 | 123.45 Million CNY | 0.0% |
| 2016 Q2 | 123.45 Million CNY | 0.0% |
| 2016 Q3 | 142.32 Million CNY | 15.29% |
| 2016 Q4 | 142.32 Million CNY | 0.0% |
| 2016 FY | 142.32 Million CNY | -17.69% |
| 2015 FY | 172.9 Million CNY | -39.82% |
| 2014 FY | 287.32 Million CNY | 40.88% |
| 2013 FY | 203.94 Million CNY | 0.0% |